The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation

Mária Vilková & Ján Mojžiš et al. · 2024-07-09

Ovarian cancer ranks among the most severe forms of cancer affecting the female reproductive organs, posing a significant clinical challenge primarily due to the development of resistance to conventional therapies. This study investigated the effects of the chalcone derivative 1C on sensitive (A2780) and cisplatin-resistant (A2780cis) ovarian cancer cell lines. Our findings revealed that 1C suppressed cell viability, induced cell cycle arrest at the G2/M phase, and triggered apoptosis in both cell lines. These effects are closely associated with generating reactive oxygen species (ROS). Mechanistically, 1C induced DNA damage, modulated the activity of p21, PCNA, and phosphorylation of Rb and Bad proteins, as well as cleaved PARP. Moreover, it modulated Akt, Erk1/2, and NF-κB signaling pathways. Interestingly, we observed differential effects of 1C on Nrf2 levels between sensitive and resistant cells. While 1C increased Nrf2 levels in sensitive cells after 12 h and decreased them after 48 h, the opposite effect was observed in resistant cells. Notably, most of these effects were suppressed by the potent antioxidant N-acetylcysteine (NAC), underscoring the crucial role of ROS in 1C-induced antiproliferative activity. Moreover, we suggest that modulation of Nrf2 levels can, at least partially, contribute to the antiproliferative effect of chalcone 1C.

Funding
Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Repub-lic Grant VEGA 1/0539/21Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Repub-lic Grant VEGA 1/0498/23Slovak Research and Development Agency Grant APVV-16-0446EDRF Grant ITMS2014+: 313011V455EDRF Grant ITMS2014 + 313011D103Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA Grant VEGA 1/0539/21Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA Grant VEGA 1/0498/23Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA Grant APVV-16-0446Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA Grant ITMS2014+: 313011V455Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA Grant ITMS2014 + 313011D103Slovak Research and Development Agency Grant VEGA 1/0539/21Slovak Research and Development Agency Grant VEGA 1/0498/23Slovak Research and Development Agency Grant ITMS2014+: 313011V455Slovak Research and Development Agency Grant ITMS2014 + 313011D103Open scientific community for modern interdisciplinary research in medicine (OPENMED) Grant VEGA 1/0539/21Open scientific community for modern interdisciplinary research in medicine (OPENMED) Grant VEGA 1/0498/23Open scientific community for modern interdisciplinary research in medicine (OPENMED) Grant APVV-16-0446Open scientific community for modern interdisciplinary research in medicine (OPENMED) Grant ITMS2014+: 313011V455Open scientific community for modern interdisciplinary research in medicine (OPENMED) Grant ITMS2014 + 313011D103